معرفی
Andrea Benedetti, PhD is an Associate Professor in the Department of Medicine, Faculty of Medicine and Health Sciences at McGill University, and a Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) at the 5252 de Maisonneuve site. She is affiliated with the Translational Research in Respiratory Diseases Program and the Centre for Outcomes Research and Evaluation (CORE), focusing on biostatistics and epidemiology research related to respiratory diseases, tuberculosis, and chronic obstructive pulmonary disease.
Dr. Benedetti's research primarily focuses on statistical methodology development to help researchers make the best use of their data. She specializes in methods for analyzing individual patient data meta-analysis, smoothing in mixed models, and methods to analyze clustered or longitudinal data. Her collaborative work spans depression screening and respiratory health, with active collaborations in tuberculosis, COPD, and asthma research. Her expertise bridges advanced statistical techniques with practical clinical applications across multiple medical disciplines.
Her publication record demonstrates significant contributions across multiple domains including depression screening tools, tuberculosis prevention and treatment, COPD and cardiovascular disease relationships, and statistical methodology development. Her work often involves large-scale meta-analyses and collaborative studies across multiple institutions and countries, particularly in respiratory health and mental health screening. The research shows consistent focus on methodological rigor while addressing clinically relevant questions that impact patient care and public health policy.
Dr. Benedetti has made notable contributions to depression screening tools validation through the DEPRESsion Screening Data (DEPRESSD) Collaboration, and to tuberculosis research through the RATIONS trial investigating nutritional supplementation for TB prevention. She is also involved with the Scleroderma Patient-centered Intervention Network (SPIN), applying her statistical expertise to research on anxiety, fatigue, and coping strategies in systemic sclerosis.
Her research has important implications for clinical practice guidelines and public health policy, particularly in the areas of depression detection in primary care settings and evidence-based approaches for tuberculosis prevention in high-risk populations. Through her position at McGill University and RI-MUHC, she contributes to training the next generation of biostatisticians and clinical researchers.